Xeris Biopharma Holdings reported revenue of $92.10M and net income of -$31.10M for the quarter ended Jun 2026, up 28.7% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||
| Revenue | 11.06M | 21.43M | 22.07M | 25.31M | 29.73M | 33.14M | 33.20M | 38.01M | 48.32M | 44.39M | 40.64M | 48.06M | 54.27M | 60.10M | 60.12M | 71.54M | 74.38M | 85.81M | 83.13M | 92.10M | ||||
| Cost of RevenueCost of Rev | 3.22M | 4.89M | 6.27M | 4.81M | 5.26M | 6.29M | 5.32M | 7.55M | 8.20M | 7.57M | 5.97M | 7.79M | 13.59M | 9.48M | 8.73M | 11.90M | 11.00M | 10.95M | 10.57M | 12.51M | ||||
| Gross Profit | 7.84M | 16.54M | 15.80M | 20.50M | 24.46M | 26.85M | 27.88M | 30.45M | 40.12M | 36.82M | 34.67M | 40.27M | 40.67M | 50.62M | 51.39M | 59.64M | 63.38M | 74.86M | 72.55M | 79.59M | ||||
| Operating items | ||||||||||||||||||||||||
| Amortization - Intangibles | 0.55M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | |||||
| Research & DevelopmentR&D | 5.66M | 10.08M | 6.25M | 3.72M | 6.04M | 4.96M | 4.84M | 6.09M | 5.03M | 6.38M | 7.82M | 5.76M | 5.89M | 6.09M | 7.75M | 8.05M | 7.48M | 7.87M | 8.78M | 10.67M | ||||
| Selling, General & AdministrativeSG&A | 26.54M | 54.18M | 35.91M | 32.98M | 34.49M | 34.36M | 33.60M | 37.63M | 37.29M | 37.57M | 38.38M | 39.99M | 44.97M | 40.14M | 44.02M | 44.39M | 46.46M | 47.50M | 53.14M | 61.03M | ||||
| Other Operating ExpensesOther Opex | 3.22M | 5.44M | 8.98M | 7.52M | 7.97M | 9.00M | 8.03M | 10.27M | 10.91M | 10.28M | 8.68M | 10.50M | 16.30M | 12.19M | 11.44M | 14.61M | 13.71M | 13.66M | 13.28M | 15.22M | ||||
| Operating ExpensesOpex | 35.42M | 69.70M | 51.15M | 44.22M | 48.51M | 48.31M | 46.47M | 53.99M | 53.23M | 54.23M | 54.88M | 56.25M | 67.16M | 58.42M | 63.21M | 67.06M | 67.65M | 69.03M | 75.21M | 86.93M | ||||
| Operating IncomeOp. Inc | -24.36M | -48.27M | -29.07M | -18.92M | -18.78M | -15.17M | -13.28M | -15.98M | -4.91M | -9.84M | -14.24M | -8.19M | -12.89M | 1.68M | -3.09M | 4.48M | 6.73M | 16.77M | 7.92M | 5.17M | ||||
| EBIT | -24.36M | -48.27M | -29.07M | -18.92M | -18.78M | -15.17M | -13.28M | -15.98M | -4.91M | -9.84M | -14.24M | -8.19M | -12.89M | 1.68M | -3.09M | 4.48M | 6.73M | 16.77M | 7.92M | 5.17M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.80M | 1.80M | 3.52M | 3.45M | 4.00M | 4.37M | 6.22M | 6.53M | 6.85M | 7.01M | 7.03M | 8.00M | 7.80M | 7.70M | 7.30M | 7.40M | 7.30M | 7.17M | 6.90M | 6.95M | ||||
| Interest & Investment IncomeInt & Inv Inc | 0.07M | 0.07M | 0.07M | 0.20M | 0.47M | 1.84M | 1.30M | 1.22M | 1.12M | 1.11M | 1.92M | 1.29M | 1.20M | 0.91M | 1.18M | 0.95M | 1.16M | 1.46M | 1.20M | 1.46M | ||||
| Other Non Operating IncomeOther Non Op Inc. | -1.65M | -2.52M | -5.05M | -7.61M | -3.39M | 1.90M | -3.56M | -4.54M | -7.61M | -2.80M | -4.43M | -6.07M | -6.17M | -6.79M | -6.13M | -6.41M | -6.11M | -5.69M | -5.68M | -36.27M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | -26.01M | -50.79M | -34.12M | -26.52M | -22.17M | -13.27M | -16.83M | -20.52M | -12.53M | -13.63M | -18.67M | -14.26M | -19.06M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Tax ProvisionsTaxes | -0.41M | -0.34M | -0.34M | -0.34M | -0.68M | -0.34M | -0.24M | 0.31M | 0.75M | -3.32M | ||||||||||||||
| Profit After TaxPAT | -26.02M | -50.80M | -33.71M | -26.18M | -21.83M | -12.92M | -16.83M | -19.84M | -12.19M | -13.37M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Income from Continuing OperationsIncome (Continuing) | -26.01M | -50.79M | -33.71M | -26.18M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Consolidated Net IncomeConsol Net Inc. | -26.01M | -50.79M | -33.71M | -26.18M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Income towards Parent CompanyParent Net Inc | -26.01M | -50.79M | -33.71M | -26.18M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Net Income towards Common StockholdersNet Income | -26.01M | -50.79M | -33.71M | -26.18M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -0.39 | -0.64 | -0.25 | -0.19 | -0.16 | -0.10 | -0.12 | -0.14 | -0.09 | -0.10 | -0.14 | -0.10 | -0.11 | -0.03 | -0.06 | -0.01 | 0.00 | 0.07 | 0.01 | -0.18 | ||||
| EPS (Diluted) | -0.39 | -0.64 | -0.25 | -0.19 | -0.16 | -0.10 | -0.12 | -0.14 | -0.09 | -0.10 | -0.14 | -0.10 | -0.11 | -0.03 | -0.06 | -0.01 | 0.00 | 0.06 | 0.01 | -0.18 | ||||
| Shares Outstanding | 66.50M | 79.03M | 135.03M | 135.53M | 135.95M | 135.63M | 137.14M | 137.34M | 138.06M | 137.67M | 140.51M | 148.35M | 148.99M | 146.77M | 152.45M | 159.46M | 163.65M | 160.43M | 170.52M | 172.82M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 66.50M | 79.03M | 135.03M | 135.53M | 135.95M | 135.63M | 137.14M | 137.34M | 138.06M | 137.67M | 140.51M | 148.35M | 148.99M | 146.77M | 152.45M | 159.46M | 177.62M | 172.74M | 177.63M | 172.82M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 66.50M | 79.03M | 135.53M | 135.96M | 135.96M | 136.27M | 137.29M | 138.01M | 138.07M | 138.13M | 148.22M | 148.94M | 149.00M | 149.43M | 156.01M | 161.22M | 165.53M | 166.22M | 172.56M | 173.59M | ||||
| EBITDA | -24.36M | -48.27M | -29.07M | -18.92M | -18.78M | -15.17M | -13.28M | -15.98M | -4.91M | -9.84M | -14.24M | -8.19M | -12.89M | 1.68M | -3.09M | 4.48M | 6.73M | 16.77M | 7.92M | 5.17M | ||||
| Interest ExpensesInt Expense | 1.80M | 1.80M | 3.52M | 3.45M | 4.00M | 4.37M | 6.22M | 6.53M | 6.85M | 7.01M | 7.03M | 8.00M | 7.80M | 7.70M | 7.30M | 7.40M | 7.30M | 7.17M | 6.90M | 6.95M | ||||
| Tax Rate | 1.20% | 1.28% | 1.53% | 2.55% | 3.29% | 2.70% | 1.73% | -1.64% | -5.25% | 17.44% |